International Vegetative State and Consciousness Science Institute, Hangzhou Normal University
Hangzhou, Zhejiang, 3100036, China
NCT Number: NCT03494218
The aim of this study was to translate the NCS from English into Chinese and determine the validity of this Chinese version.
Looking for future studies?
Notify Me19 year–53 year
All sexes
Interventional
Not applicable
Hangzhou, Zhejiang, 3100036, China
The assessment and early diagnosis of pain is of great importance for pain management and treatment in patients with disorders of consciousness. The Nociception Coma Scale (- Revised) is only applicable to assess pain of DOC patients in international clinical setting. The aim of this study was to translate the NCS from English into Chinese and determine the validity of this Chinese version. To test internal reliability and inter-rater reliability, both rater A and rater B assess the perception of pain on day 1; and to obtain test-retest reliability, rater A assessed all patients repeatedly on day 2. 'Faces, Legs, Activity, Cry, Consolability' (FLACC) was used to analysis concurrent validity by rater A.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients have been assessed with both the Nociception Coma Scale (NCS) and the FLACC.
Other names: the Face Legs Activity Cry and Consolability (FLACC)
Time frame: Within 2 days
This original NCS consists of four subscales to assess motor, verbal, visual and facial behavioral responses and each subscale score ranges from 0 to 3
Hangzhou Normal University
Other
Reliability and Validity of the Nociception Coma Scale (-Revised)-Chinese Version
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04065386
Brain Damage, Chronic, Brain Diseases
Ottignies-Louvain-la-Neuve, Brabant Wallon, Belgium
View Trial DetailsNCT05536921
Brain Damage, Chronic, Brain Diseases
Częstochowa, Poland
View Trial DetailsNCT04921683
Anoxia, Brain, Brain Damage, Chronic
Pomona, California, United States
View Trial DetailsNCT04687553
Brain Damage, Chronic, Brain Diseases
Hangzhou, Zhejiang, China
View Trial Details